According to GuruFocus Insider Data, the recent CFO sales were: Facebook Inc., Workday Inc, and Gilead Sciences Inc.
Facebook Inc. (FB, Financial): CFO David Ebersman sold 23,400 Shares
On May 29, CFO David Ebersman sold 23,400 shares at an average price of $63.62. The price of the stock has increased by 1.38% since. Facebook has a market cap of $165.53 billion and its shares were traded at around $64.50. The company has a P/E ratio of 85.70 and P/S ratio of 18.48.
Facebook announced their 2014 first quarter results with revenues of $2.5 billion and gross profit of $2.04 billion; the net income was $639 million. The 2013 total revenue was $7.87 billion, a 55% increase from the 2012 total revenue. The 2013 gross profit was $6 billion, a 61% increase from the 2012 gross profit. The 2013 net income was $1.5 billion.
On June 18, COO Sheryl Sandberg sold 283,334 shares at an average price of $64.64. The price of the stock has decreased by 0.22% since. On June 17, Chief Technology Officer Michael Todd Schroepfer sold 29,784 shares at an average price of $64.07. The price of the stock has increased by 0.67% since. On June 16, Chief Product Officer Christopher Cox sold 14,267 shares at an average price of $64.11. The price of the stock has increased by 0.61% since.
Workday (WDAY, Financial): CFO Mark Peek sold 40,000 Shares
On June 17, CFO Mark Peek sold 40,000 shares at an average price of $85.81. The price of the stock has decreased by 1.11% since. Workday Inc. has a market cap of $15.7 billion and its shares were traded at around $84.86. The company has a P/S ratio of 27.82.
Workday Inc. announced their 2014 second quarter results with revenues of $159.74 million and gross profit of $102.32 million; the net income was $59.39 million. The 2014 total revenue was $468.9 million, a 71% increase from the 2013 total revenue. The 2014 gross profit was $292.13 million, an 86% increase from the 2013 gross profit. The 2014 net income was $172.5 million.
On June 12, CEO, 10% Owner Aneel Bhusri sold 62,500 shares at an average price of $80.70. The price of the stock has increased by 5.15% since. On June 19, President and COO Michael A Stankey sold 147,500 shares at an average price of $86.27. The price of the stock has decreased by 1.63% since. On June 11, Senior Vice President James Bozzini sold 21,000 shares at an average price of $80.29. The price of the stock has increased by 5.9% since.
Gilead Sciences Inc. (GILD, Financial): EVP, CFO Robin Washington sold 6,426 Shares
On June 14, EVP, CFO Robin Washington sold 6,426 shares at an average price of $82.52. The price of the stock has decreased by 1.6% since. Gilead Sciences has a market cap of $124.7 billion and its shares were traded at around $81.20. The company has a P/E ratio of 29.80 and P/S ratio of 10.06. Over the past 5 years, Gilead Sciences Inc had an annual average earnings growth of 8.20%.
Gilead Sciences Inc. announced their 2014 first quarter results with revenues of $4.99 billion and gross profit was $4.19 billion; the net income was $2.23 billion. The 2013 total revenue was $11.2 billion, a 15% increase from the 2012 total revenue. The 2013 gross profit was $8.34 billion, a 15% increase from the 2012 gross profit. The 2013 net income was $3.1 billion.
On June 2, Chairman and CEO John C Martin sold 140,625 shares at an average price of $81.32. The price of the stock has decreased by 0.15% since. On June 16, EVP, R&D and CSO Norbert W Bischofberger sold 90,000 shares at an average price of $80.90. The price of the stock has increased by 0.37% since. On 06/09/2014, EVP Commercial Ops Paul Rutherford Carter sold 16,728 shares at an average price of $79.43. The price of the stock has increased by 2.23% since.
